ARCHIVES

Chemoprevention Concept Approved By DCPC Bard Uses Biological Markers To Assess Risk Modulation

This article is from The Cancer Letter archive.

Vol. 11 No. 37 | September 27, 1985

Download PDF Visit The Full Archive

Related Articles

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

December 14, 2001

In Brief: Margaret Holms Names Centers Branch Chief; Kimes To Recruit As Special Assistant

March 30, 1990

USC Cancer Center Plans Expansion, Gets New Name

January 27, 1989

ASCO Growth Changes, Prepare Society for ‘90s

June 8, 1990

NCI Launches Effort In Cancer Education For Older Americans; Also An ACS Goal, Dodd Tells Writers

March 29, 1991

It’s Official : PRI Wins Massive FCRF Contract ; DMS Keeps Library, Lands Computer Servicea

September 18, 1987